December 2007
M	T	W	T	F	S	S
« Nov		Jan »
	1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

Medical Articles 12/28

Posted by rob on December 28, 2007 under Uncategorized | Be the First to Comment

Lyl1 Interacts with CREB1 and Alters Expression of CREB1 Target Genes.

A
half-log increase in BCR-ABL RNA predicts a higher risk of relapse in
patients with chronic myeloid leukemia with an imatinib-induced
complete cytogenetic response.

Serglycin proteoglycan in hematologic malignancies: a marker of acute myeloid leukemia.

The
severity of FIP1L1-PDGFRA-positive chronic eosinophilic leukaemia is
associated with polymorphic variation at the IL5RA locus.

Marrow fibrosis and its relevance during imatinib treatment of chronic myeloid leukemia.

Deregulation of the Wilms’ tumour gene 1 protein (WT1) by BCR/ABL1 mediates resistance to imatinib in human leukaemia cells.

Pleiotropic p27(Kip1), BCR-ABL and leukemic stem cell: the trio in concert.

Powered by ScribeFire.

Medical Articles 12/27

Posted by rob on under Uncategorized | Be the First to Comment

A
Prognostic Score for Patients with Acute Leukemia or Myelodysplastic
Syndromes Undergoing Allogeneic Stem Cell Transplantation.

Single chromosomal abnormalities in Philadelphia-negative chronic myeloproliferative disorders.

Successful bone marrow transplantation for treatment of chronic myeloid leukemia from a donor with mosaic Klinefelter syndrome.

Comparison
of myeloablative and nonmyeloablative hematopoietic stem cell
transplantation for treatment of chronic myeloid leukemia.

Cytogenetic
remissions induced by interferon alpha and imatinib mesylate are
immunologically distinct in chronic myeloid leukemia.

Dynamics
of BCR-ABL kinase domain mutations in chronic myeloid leukemia after
sequential treatment with multiple tyrosine kinase inhibitors.

Most
CML patients who have a suboptimal response to imatinib have low OCT-1
activity: higher doses of imatinib may overcome the negative impact of
low OCT-1 activity.

Acquired hematopoietic stem-cell disorders and mammalian size.

Chemical
proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and
dasatinib reveal novel kinase and nonkinase targets.

Powered by ScribeFire.

Christmas

Posted by rob on December 25, 2007 under Uncategorized | Be the First to Comment

From 713 Avenue

Powered by ScribeFire.

Horses

Posted by rob on under Uncategorized | Be the First to Comment

From Jom Manilat

Powered by ScribeFire.

Medical Articles 12/23

Posted by rob on December 23, 2007 under Uncategorized | Be the First to Comment

Exploiting Signal Transduction Pathways in Acute Myelogenous Leukemia.

Targeted chronic myeloid leukemia therapy: Seeking a cure.

Chronic myeloid leukemia in 2007.

Leukemia. Q&A highlights.

Chronic myeloid leukemia. Introduction.

New strategies in controlling drug resistance in chronic myeloid leukemia.

Powered by ScribeFire.

Medical Articles 12/22

Posted by rob on December 22, 2007 under Uncategorized | Be the First to Comment

[Clinical
Significance of Quantitation of WT1 Gene Expression for Minimal
Residual Disease Monitoring of Acute Myelogenous Leukemia.]

[Prevalence of FLT3 Internal Tandem Duplication in Adult Acute Myelogenous Leukemia.]

[Incidence and clinical significance of sex chromosome losses in bone marrow of patients with hematologic diseases.]

Part II: management of resistance to imatinib in chronic myeloid leukaemia.

Novel role of HDAC inhibitors in AML1/ETO AML cells: activation of apoptosis and phagocytosis through induction of annexin A1.

[Karyotype analysis in 119 patients with chronic myeloid leukemia at blast crisis]

Powered by ScribeFire.

Medical Articles 12/20

Posted by rob on December 21, 2007 under Uncategorized | Be the First to Comment

MUC1 oncoprotein regulates Bcr-Abl stability and pathogenesis in chronic myelogenous leukemia cells.

[STI571 Induces Apoptosis of K562 Cells through Down-regulation of Anti-apoptotic Protein Mcl-1 and Bcl-xl Expression.]

Part I: mechanisms of resistance to imatinib in chronic myeloid leukaemia.

Powered by ScribeFire.

Medical Articles 12/19

Posted by rob on December 20, 2007 under Uncategorized | Be the First to Comment

Cytogenetic and molecular responses and outcome in chronic myelogenous leukemia: need for new response definitions?

FDG PET findings of chronic myeloid leukemia in the chronic phase before and after treatment.

[Detection of SOCS-1 mRNA expression by RT-PCR in the patients with myeloid leukemia]

[Effect of heat stress on expression of gp96 in K562 cell line of the chronic myeloid leukemia and its significance]

[Prognostic analysis of chronic myeloid leukemia with Cox model and the Sokal, Hasford score]

[Expressions of CD117 and CD11b in patients with APL at diagnosis and post-treatment]

Powered by ScribeFire.

Medical Articles 12/17

Posted by rob on December 17, 2007 under Uncategorized | Be the First to Comment

A prognostic score for patients with lower risk myelodysplastic syndrome.

[An Advance in the Treatment of CML.]

[Using real-time polymerase chain reaction to quantitate bcr-abl mRNA]

[Chronic myeloid leukemia onset with marked thrombocythemia]

Powered by ScribeFire.

Medical Articles 12/14

Posted by rob on December 14, 2007 under Uncategorized | Be the First to Comment

Recent developments in acute myelogenous leukemia therapy.

Difficulties with fungal infections in acute myelogenous leukemia patients: immune enhancement strategies.

Innovative approaches in the treatment and support of patients with acute myelogenous leukemia.

Home For The Holidays

Posted by rob on under Uncategorized | Be the First to Comment

From -Teddy

Archives

Recent Posts

Meta

Medical Articles 12/28

Medical Articles 12/27

Christmas

Horses

Medical Articles 12/23

Medical Articles 12/22

Medical Articles 12/20

Medical Articles 12/19

Medical Articles 12/17

Medical Articles 12/14

Home For The Holidays

Site Information

Pages

Blogroll

Contributors